• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Impact
    • Our Team
    • Our Partners
  • For Scientists
    • Research Core Facilities
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Genomic Datasets
      • Animal Models
      • In Vivo Target Validation Core
      • Stem Cell Core
      • Antibody Core
      • Viral Vector Core
    • Funding Opportunities
    • Funded Consortia
    • Annual Meeting
  • ALS Resources
    • The Science, Explained
    • Glossary
    • FAQ
    • Blog
    • Video Library
  • Take Action
    • Contact Us
    • Email Sign Up
    • Donate Now
    • Ways to Give
    • Donate Biofluid Samples
    • Corporate Council

Glossary

Amyotrophic lateral sclerosis, more commonly known as ALS, is a progressive neurodegenerative disease in the central nervous system that impacts the brain and spinal cord, resulting in a loss of muscle control.

It is colloquially referred to as Lou Gehrig’s Disease, after the famous baseball player who battled it in the late 1930s, and does not yet have a cure. To better understand the language of ALS, the ALS Glossary below provides definitions for research terms commonly used by our Innovation Ecosystem and the extended ALS community.

ABCDEFGHIKLMNPRSTUWAll

metadata

Information describing data. In genomic research, metadata includes where/how the DNA or RNA sequence was obtained, allowing researchers to reproduce or retrieve data more easily.

motor neuron disease

A group of disorders in which motor nerve cells (neurons) in the spinal cord and brain stem deteriorate and die. ALS is the most common motor neuron disease

multiple sclerosis (MS)

An autoimmune disease affecting the central nervous system. MS involves the gradual destruction of myelin (the protective covering of nerves) throughout the brain and/or spinal cord. This interferes with nerve pathways, causing muscular weakness, loss of coordination and speech and visual disturbances.

muscle atrophy

Loss of muscle fiber volume that leads to a visible decrease in muscle size.

muscular dystrophy (MD)

A group of muscle diseases caused by progressive muscle degeneration and weakness due to the alterations of proteins involved in muscle health.

myasthenia gravis (MG)

A chronic autoimmune, neuromuscular disease that causes weakness and fatigue in the skeletal muscles, affecting the eyes, face, neck, and limbs. Its name means "grave muscular weakness."

Footer

  • Challenge
  • Contact
  • Our Approach
  • Resources For Scientists
  • Donate
  • Call For Proposals
  • Funded Consortia
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

guidestar charity-navigator

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
P.O. Box 1598
New York, NY 10101
(332) 333-4140
Steck Insights WordPress Consulting